Platform enables consistent production of high-quality data and increases the pace of innovation at CROs and PROs Basel, Switzerland – Genedata, a leading provider of advanced software solutions for R&D, today announced that Axxam has extended its licensing of Genedata Screener® as its collaborative research platform for data analysis of high-throughput screening, compound profiling, and safety screening campaigns. […]
Industry veteran joins Cerno Bioscience to drive direct and channel sales of current and next generation Mass Spectrometry software. Norwalk, CT Cerno Bioscience, a leader in the application of modern mathematical techniques to mass spectrometry, announced today that Steve Best has joined the company in the role of Director of Sales, North America. Steve will […]
CAMBRIDGE, Mass. and HANGZHOU, China — 1CellBiO Inc., a leading single-cell analysis company serving the biomedical research community, today announced that it has signed a reseller and license agreement with Hangzhou Chengyuan Genomics Company (Chengyuan), a premier life-science research and development start-up based in Hangzhou, China. Under the agreement, Chengyuan has agreed to provide single cell analysis research services to […]
Cambridge, UK OncoSpan features the largest gene coverage of any oncology reference standard Allows the most comprehensive validation of oncology gene panels and large-scale exome sequencing assays OncoSpan is supplied with free-of-charge access to online NGS validation and quality control (QC) tool, OncoMatic Cambridge, UK: Horizon Discovery (LSE: HZD) (“Horizon” or “the Company”), a global leader […]
ST LOUIS – PierianDx, the forerunner in clinical genomic analysis, interpretation and reporting, announced that its leading, integrated “one space” genomics workflow and analysis solution, Clinical Genomicist Workspace (CGW), now supports clinical microarray (CMA) technology. CMA is commonly used in the constitutional setting to evaluate complex developmental disorders and is used to identify potential copy number […]
Concord, MA – N-of-One, Inc., the leader in clinical interpretation of molecular tests in oncology, is proud to announce the incorporation of the recent AMP guidelines on reporting somatic cancer variants with enhanced levels of evidence (LOE) into N-of-One’s existing curation and reporting. In December of 2016, to address the field’s need for consistent interpretation and […]
SAN DIEGO – Edico Genome today announced the availability of its DRAGENTM Bio-IT Platform on Illumina’s BaseSpace® Sequence Hub, enabling users to now run DRAGEN instances to enhance the accuracy and speed of their secondary analysis of next-generation sequencing data. Powered by Amazon Web Services’ (AWS) new reconfigurable Field Programmable Gate Array (FPGA) enabled F1 instances, Edico Genome’s ultra-rapid DRAGEN Genome Pipeline features optimized […]
36 leading biopharmaceutical companies now participate in this unique global modeling and simulation research group PRINCETON, NJ – Certara®, the global leader in model-informed drug development and regulatory science, today announced that Kyowa Hakko Kirin Co., Ltd. has joined the Simcyp Consortium and licensed the Simcyp® Population-based Simulator. Kyowa Hakko Kirin is the 36th leading biopharmaceutical company […]
OAKLAND, Calif. & SAN FRANCISCO, Calif.–Fabric Genomics and Genome Medical announced today that they have entered into a partnership with the goal of bringing expert medical interpretation and counseling around genomic data directly to physicians and patients. Genome Medical will use Fabric Genomics’ clinical interpretation platform, Fabric Enterprise™, for ongoing examination of its patients’ genomic data to augment data […]
LAUSANNE, Switzerland SOPHiA GENETICS, the global leader in Data-Driven Medicine that has created SOPHiA Artificial Intelligence, today announced the close of a $30 million Series D funding round. The round was led by London-based Balderton Capital joined by 360º Capital Partners alongside existing investors British tech star Mike Lynch’s Invoke Capital and Alychlo, the investment firm of Belgian pharmaceutical entrepreneur Marc Coucke. […]
Pay Invoice
Latest Blogs
-
Automation Provides a Boost for Sample Prep Instrument Market Growth
August 25, 2026 11:49 am
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
